Himuro Nobuaki, Mishima Reiko, Seshimo Takashi, Morishima Toshibumi, Kosaki Keisuke, Ibe Shigeharu, Asagai Yoshimi, Minematsu Koji, Kurita Kazuhiro, Okayasu Tsutomu, Shimura Tsukasa, Hoshino Kotaro, Suzuki Toshiro, Yanagizono Taiichiro
Department of Public Health, School of Medicine, Sapporo Medical University, Sapporo, Hokkaido, Japan.
Asahikawa Center for Disabled Children, Asahikawa, Hokkaido, Japan.
NeuroRehabilitation. 2018;42(4):383-390. doi: 10.3233/NRE-172340.
The prognosis for mobility function by Gross Motor Function Classification System (GMFCS) level is vital as a guide to rehabilitation for people with cerebral palsy.
This study sought to investigate change in mobility function and its causes in adults with cerebral palsy by GMFCS level.
We conducted a cross-sectional questionnaire study.
A total of 386 participants (26 y 8 m, SD 5 y 10 m) with cerebral palsy were analyzed. Participant numbers by GMFCS level were: I (53), II (139), III (74) and IV (120). The median age of participants with peak mobility function in GMFCS level III was younger than that in the other levels. 48% had experienced a decline in mobility. A Kaplan-Meier plot showed the risk of mobility decline increased in GMFCS level III; the hazard ratio was 1.97 (95% CI, 1.20-3.23) compared with level I. The frequently reported causes of mobility decline were changes in environment, and illness and injury in GMFCS level III, stiffness and deformity in level IV, and reduced physical activity in level II and III.
Peak mobility function and mobility decline occurred at a younger age in GMFCS level III, with the cause of mobility decline differing by GMFCS level.
粗大运动功能分类系统(GMFCS)水平对脑瘫患者运动功能预后至关重要,可作为康复指南。
本研究旨在按GMFCS水平调查成年脑瘫患者运动功能变化及其原因。
我们进行了一项横断面问卷调查研究。
共分析了386例脑瘫患者(平均年龄26岁8个月,标准差5岁10个月)。GMFCS各水平的患者数量分别为:I级(53例)、II级(139例)、III级(74例)和IV级(120例)。GMFCS III级中运动功能达到峰值的参与者的年龄中位数低于其他水平。48%的患者运动功能出现下降。Kaplan-Meier曲线显示,GMFCS III级运动功能下降风险增加;与I级相比,风险比为1.97(95%CI,1.20 - 3.23)。运动功能下降的常见原因在GMFCS III级为环境变化、疾病和损伤,IV级为僵硬和畸形,II级和III级为体力活动减少。
GMFCS III级运动功能峰值和运动功能下降出现在较年轻的年龄,运动功能下降的原因因GMFCS水平而异。